产品中心 流式试剂&相关 流式抗体

所有图片(1/1)

FITC Mouse Anti-Human CD19 Antibody (S-R503-2)

B-lymphocyte antigen CD19,B-lymphocyte surface antigen B4,Differentiation antigen CD19,T-cell surface antigen Leu-12

价格 400.00 1-2周
货号 S0B5860
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    CD19
  • 分子别名

    B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12
  • 细胞定位

    Cell membrane
  • Accession

    P15391
  • 克隆号

    S-R503-2
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG1
  • 反应种属 ?

    Hu
  • 阳性样本

    Human PBMC
  • 纯化方式

    Protein G
  • 浓度

    0.2 mg/ml
  • 标记

    FITC
  • 性状

    Liquid
  • 缓冲体系

    PBS, 1% BSA, 0.3% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

  • 应用

    FCM

  • 稀释度

    应用 稀释度 推荐种属
    FCM 5μl per million cells in 100μl volume Hu
背景介绍
  • CD19, also known as B-lymphocyte antigen CD19 or B-Lymphocyte Surface Antigen B4, is a 95 kDa type I transmembrane glycoprotein that belongs to the immunoglobulin superfamily and is encoded by the CD19 gene. It is primarily expressed on all B lineage cells, from early pro-B cells to plasma cells, and plays a crucial role in B cell development, activation, and signaling. As a co-receptor, CD19 enhances signaling through the B cell receptor (BCR) complex, lowering the threshold for B cell activation and promoting B cell proliferation and differentiation. It forms a complex with CD21, CD81, and other proteins, which helps in the recognition of antigens tagged with complement and amplifies BCR signaling. CD19 is also a biomarker for B cell-related diseases and a target for immunotherapies, including monoclonal antibodies and CAR-T cell therapies, due to its consistent expression on B cells and B cell malignancies.

  • 流式分析

    • Flow cytometric analysis of Human CD19 expression on Human PBMC. Human PBMC (peripheral blood mononuclear cells) were stained with either FITC Mouse IgG1 Isotype Control (Left panel) or FITC Mouse Anti-Human CD19 Antibody (Right panel) at 1.25 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.

评论(0)